Infectious diseases specialist Dr. Isaac Bogoch explains the new findings of clinical trials for the Pfizer-BioNTech vaccine on children between the ages of 5-11 and how soon it could be approved for use for that age group.
- Ontario reports 574 new COVID-19 cases, 8 deaths
- Pfizer Canada eyeing urgent COVID-19 vaccine approval for children aged 5 to 11
- Daily COVID-19 infections 2nd highest, with 56 in Saskatchewan ICUs